tiprankstipranks
Trending News
More News >
Wockhardt Limited (IN:WOCKPHARMA)
:WOCKPHARMA
India Market
Advertisement

Wockhardt Limited (WOCKPHARMA) Price & Analysis

Compare
2 Followers

WOCKPHARMA Stock Chart & Stats


Financials

WOCKPHARMA FAQ

What was Wockhardt Limited’s price range in the past 12 months?
Wockhardt Limited lowest stock price was ₹835.15 and its highest was ₹1870.00 in the past 12 months.
    What is Wockhardt Limited’s market cap?
    Wockhardt Limited’s market cap is ₹276.35B.
      When is Wockhardt Limited’s upcoming earnings report date?
      Wockhardt Limited’s upcoming earnings report date is Aug 08, 2025 which is in 13 days.
        How were Wockhardt Limited’s earnings last quarter?
        Wockhardt Limited released its earnings results on May 29, 2025. The company reported -₹1.539 earnings per share for the quarter, missing the consensus estimate of N/A by -₹1.539.
          Is Wockhardt Limited overvalued?
          According to Wall Street analysts Wockhardt Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Wockhardt Limited pay dividends?
            Wockhardt Limited pays a Notavailable dividend of ₹9.218 which represents an annual dividend yield of N/A. See more information on Wockhardt Limited dividends here
              What is Wockhardt Limited’s EPS estimate?
              Wockhardt Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Wockhardt Limited have?
              Wockhardt Limited has 162,478,970 shares outstanding.
                What happened to Wockhardt Limited’s price movement after its last earnings report?
                Wockhardt Limited reported an EPS of -₹1.539 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.631%.
                  Which hedge fund is a major shareholder of Wockhardt Limited?
                  Currently, no hedge funds are holding shares in IN:WOCKPHARMA

                  Company Description

                  Wockhardt Limited

                  Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables, lyophilization, and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Alkem Laboratories Ltd.
                  Aurobindo Pharma Ltd
                  Dr. Reddy's Laboratories Ltd.
                  Glenmark Pharmaceuticals Limited
                  IPCA Laboratories Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis